Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Nov 21, 2024; 30(43): 4609-4619
Published online Nov 21, 2024. doi: 10.3748/wjg.v30.i43.4609
Figure 1
Figure 1 SHOX2, RNF180, and EPO expression and methylation in normal esophageal tissue (n = 11) and esophageal cancer tissue (n = 181) samples from previously reported genome data. A, C, and E: Expression of SHOX2, RNF180, and EPO was up- or downregulated in esophageal cancer (EC) tissues (n = 181); B, D, and F: Promoter methylation levels of SHOX2, RNF180, and EPO in normal esophageal tissues (n = 11) and EC tissues (n = 181), as indicated by beta values ranging from 0 (unmethylated) to 1 (fully methylated). aP < 0.05. EC: Esophageal cancer.